title: MSMB gene variant alters the association between prostate cancer and number of sexual partners.
abstract: BACKGROUND
  Recently, a genetic variant (rs10993994) in the MSMB gene associated with prostate cancer (PCa) risk was shown to correlate with reduced prostate secretory protein of 94 amino acids (PSP94) levels. Although the biological activity of PSP94 is unclear, one of its hypothesized functions is to protect prostatic cells from pathogens. Number of sexual partners and a history of sexually transmitted infections (STIs) have been positively associated with PCa risk, and these associations may be related to pathogen-induced chronic prostatic inflammation. Based on these observations, we investigated whether MSMB genotype modifies the PCa-sexual history association.
  
  
  METHODS
  We estimated odds ratios (ORs) and 95% confidence intervals (CIs) for the association between number of sexual partners and PCa by fitting logistic regression models, stratified by MSMB genotype, and adjusted for age, family history of PCa, and PCa screening history among 1,239 incident cases and 1,232 controls.
  
  
  RESULTS
  Compared with 1-4 female sexual partners, men with ≥ 15 such partners who carried the variant T allele of rs10993994 were at increased risk for PCa (OR = 1.32; 95% CI, 1.03-1.71); no association was observed in men with the CC genotype (OR = 1.03; 95% CI, 0.73-1.46; P = 0.05 for interaction). Similar estimates were observed for total sexual partners (any T allele OR = 1.37; 95% CI, 1.07-1.77; CC genotype OR = 1.11; 95% CI, 0.79-1.55; P = 0.06 for interaction).
  
  
  CONCLUSIONS
  The rs10993994 genotype in the MSMB gene modifies the association between number of sexual partners and PCa risk. These findings support a hypothesized biological mechanism whereby prostatic infection/inflammation may enhance risk of PCa.
authors.affiliation: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
authors.forename: Marni
authors.initials: M
authors.lastname: Stott-Miller
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Wright
authors.forename: Janet L
authors.initials: JL
authors.lastname: Stanford
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D020022:Genetic Predisposition to Disease / Q000235:genetics; D014644:Genetic Variation / Q000235:genetics*; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000235:genetics*; D029584:Prostatic Secretory Proteins / Q000235:genetics*; D012307:Risk Factors; D012747:Sexual Partners; D012749:Sexually Transmitted Diseases / Q000150:complications
chemical_list: D029584:Prostatic Secretory Proteins; C043076:beta-microseminoprotein
keywords: MSMB; PSP94; prostate cancer; rs10993994; sexual partners; sexually transmitted infections
references.citation: Nat Rev Cancer. 2007 Apr;7(4):256-69
references.pmid: 17384581
references.citation: Hum Mutat. 2013 Jan;34(1):149-56
references.pmid: 22887727
references.citation: BMC Cancer. 2010 Jun 24;10:326
references.pmid: 20576103
references.citation: Proc Natl Acad Sci U S A. 2009 May 12;106(19):7933-8
references.pmid: 19383797
references.citation: Am J Epidemiol. 1998 Mar 1;147(5):426-33
references.pmid: 9525528
references.citation: Nat Rev Genet. 2005 Apr;6(4):287-98
references.pmid: 15803198
references.citation: Am J Med. 1997 May 5;102(5A):3-8
references.pmid: 9217656
references.citation: Cancer. 2012 Sep 15;118(18):4437-43
references.pmid: 22411189
references.citation: Epidemiology. 2002 Jan;13(1):72-9
references.pmid: 11805589
references.citation: Fam Med. 2005 Jul-Aug;37(7):506-12
references.pmid: 15988645
references.citation: Prostate. 2010 Feb 15;70(3):333-40
references.pmid: 19790236
references.citation: Am J Epidemiol. 2001 Jun 15;153(12):1152-8
references.pmid: 11415949
references.citation: PLoS One. 2010 Oct 13;5(10):e13363
references.pmid: 20967219
references.citation: Prostate. 1998 May;35(2):109-16
references.pmid: 9568674
references.citation: Am J Epidemiol. 2008 Aug 1;168(3):250-60
references.pmid: 18556686
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):881-6
references.pmid: 10548316
references.citation: Prostate. 1999 Oct 1;41(2):99-109
references.pmid: 10477906
references.citation: J Urol. 2006 May;175(5):1937-42
references.pmid: 16600802
references.citation: Am J Public Health. 1994 Feb;84(2):197-201
references.pmid: 8296939
references.citation: Am J Epidemiol. 2000 Jun 15;151(12):1158-71
references.pmid: 10905528
references.citation: Nat Genet. 2008 Mar;40(3):310-5
references.pmid: 18264096
references.citation: J Urol. 2000 Nov;164(5):1819-24
references.pmid: 11025776
references.citation: Sex Transm Infect. 2000 Dec;76(6):474-9
references.pmid: 11221132
references.citation: Hum Mol Genet. 2009 Apr 1;18(7):1368-75
references.pmid: 19153072
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):939-45
references.pmid: 16702374
references.citation: PLoS Pathog. 2012;8(4):e1002625
references.pmid: 22496651
references.citation: Nat Genet. 2008 Mar;40(3):316-21
references.pmid: 18264097
references.citation: J Urol. 2006 Apr;175(4):1291-7
references.pmid: 16515983